Relapsed B-Cell Non-Hodgkin Lymphoma

Explore clinical trials studying Relapsed B-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed B-Cell Non-Hodgkin Lymphoma trial results

Recruiting

NCT06313957

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China

Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, China

Not Yet Recruiting

NCT07477366

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

Completed

NCT03994913

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

Active, Not Recruiting

NCT04970901

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of California San Francisco - Fresno Center for Medical Education and Research Clovis, California, United States

Scripps Health - Prebys Cancer Center San Diego, California, United States

Sylvester Comprehensive Cancer Center Miami, Florida, United States

Miami Cancer Institute Miami, Florida, United States

View all 40 locations